SS

Sritama Sen

Active Director Director DIN 08926000
DIN 08926000 First appointment Oct 2020 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2020
Shareholding value •••• Premium profile

About Sritama Sen

Data last updated:

Sritama Sen is a Director at Sparsha Infertility Centre Private Limited (since 2020). The company operates in Healthcare. Sparsha Infertility Centre Private Limited reported revenue of ₹1.50 Cr (FY 2023).

DIN 08926000
Primary Designation Director
Industry Healthcare
First Appointment 19 Oct 2020
Oldest Company Age 6 yrs
Largest company Sparsha Infertility Centre Private Limited · ₹1.50 Cr (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Oct 20202020₹1.50 Cr (FY 2023)Active

Board colleagues of Sritama Sen

Directorship timeline

Open interactive timeline →
Sparsha Infertility Centre Private Limited
Premium access

Shareholding and investment profile for Sritama Sen

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sritama Sen

Sritama Sen currently holds 1 directorship: Sparsha Infertility Centre Private Limited (Director, since 19 Oct 2020, revenue ₹1.50 Cr (FY 2023)).

Sritama Sen was first appointed on 19 Oct 2020 as Director at Sparsha Infertility Centre Private Limited.

The current boards of Sritama Sen's companies include Ananyabrata Das (Sparsha Infertility Centre Private Limited), Debalina Brahma (Sparsha Infertility Centre Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available